Strategies to Extend Thrombolytic Time Window for Ischemic Stroke Treatment: An Unmet Clinical Need

To date, reperfusion with tissue plasminogen activator (tPA) remains the gold standard treatment for ischemic stroke. However, when tPA is given beyond 4.5 hours of stroke onset, deleterious effects of the drug ensue, especially, hemorrhagic transformation (HT), which causes the most significant mor...

Full description

Saved in:
Bibliographic Details
Published in:Journal of stroke Vol. 19; no. 1; pp. 50 - 60
Main Authors: Peña, Ike dela, Borlongan, Cesar, Shen, Guofang, Davis, Willie
Format: Journal Article
Language:English
Published: Korea (South) Korean Stroke Society 01.01.2017
대한뇌졸중학회
Subjects:
ISSN:2287-6391, 1229-4101, 2287-6405
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Be the first to leave a comment!
You must be logged in first